These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 29075114

  • 21. [Therapeutic agents for disorders of bone and calcium metabolism: Minodronic acid hydrate].
    Miki T, Minamide T.
    Clin Calcium; 2007 Jan; 17(1):18-22. PubMed ID: 17211089
    [Abstract] [Full Text] [Related]

  • 22. Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.
    Zhang Y, Wang L, Song Y, Zhao X, Wong MS, Zhang W.
    Osteoporos Int; 2016 Mar; 27(3):1083-1092. PubMed ID: 26439241
    [Abstract] [Full Text] [Related]

  • 23. Bu-Shen-Tong-Luo decoction prevents bone loss via inhibition of bone resorption and enhancement of angiogenesis in ovariectomy-induced osteoporosis of rats.
    Yuan H, Xiao L, Min W, Yuan W, Lu S, Huang G.
    J Ethnopharmacol; 2018 Jun 28; 220():228-238. PubMed ID: 29317302
    [Abstract] [Full Text] [Related]

  • 24. Modulating osteoclasts with nanoparticles: A path for osteoporosis management?
    Rouco H, García-García P, Briffault E, Diaz-Rodriguez P.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jun 28; 15(4):e1885. PubMed ID: 37037204
    [Abstract] [Full Text] [Related]

  • 25. Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis?
    Liu J, Zhang H, Dong Y, Jin Y, Hu X, Cai K, Ma J, Wu G.
    Med Hypotheses; 2014 Dec 28; 83(6):694-6. PubMed ID: 25459136
    [Abstract] [Full Text] [Related]

  • 26. A bone-targeting drug-delivery system based on Semaphorin 3A gene therapy ameliorates bone loss in osteoporotic ovariectomized mice.
    Yang K, Miron RJ, Bian Z, Zhang YF.
    Bone; 2018 Sep 28; 114():40-49. PubMed ID: 29883786
    [Abstract] [Full Text] [Related]

  • 27. Bisphosphonates.
    McClung M.
    Arq Bras Endocrinol Metabol; 2006 Aug 28; 50(4):735-44. PubMed ID: 17117298
    [Abstract] [Full Text] [Related]

  • 28. Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis.
    McClung MR.
    Bone; 1996 Nov 28; 19(5 Suppl):195S-198S. PubMed ID: 8922662
    [Abstract] [Full Text] [Related]

  • 29. Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim.
    Xue L, Jiang Y, Han T, Zhang N, Qin L, Xin H, Zhang Q.
    J Ethnopharmacol; 2016 Nov 04; 192():370-381. PubMed ID: 27422162
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Small molecule inhibitor RepSox prevented ovariectomy-induced osteoporosis by suppressing osteoclast differentiation and bone resorption.
    Mei L, Sang W, Chen Z, Zheng L, Jin K, Lou C, Huang W, He D.
    J Cell Physiol; 2018 Dec 04; 233(12):9724-9738. PubMed ID: 30059597
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9.
    Li G, Bu J, Zhu Y, Xiao X, Liang Z, Zhang R.
    Int J Clin Exp Pathol; 2015 Dec 04; 8(12):15684-95. PubMed ID: 26884838
    [Abstract] [Full Text] [Related]

  • 35. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M, Luong-Nguyen NH, Baptist M, Cortesi R, Zumstein-Mecker S, Kossida S, O'Reilly T, Lane H, Susa M.
    Bone; 2004 Nov 04; 35(5):1144-56. PubMed ID: 15542040
    [Abstract] [Full Text] [Related]

  • 36. Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo.
    Baek JM, Kim JY, Yoon KH, Oh J, Lee MS.
    Int J Biol Sci; 2016 Nov 04; 12(5):478-88. PubMed ID: 27019631
    [Abstract] [Full Text] [Related]

  • 37. Estrogen inhibits osteoclasts formation and bone resorption via microRNA-27a targeting PPARγ and APC.
    Guo L, Chen K, Yuan J, Huang P, Xu X, Li C, Qian N, Qi J, Shao Z, Deng L, He C, Xu J.
    J Cell Physiol; 2018 Jan 04; 234(1):581-594. PubMed ID: 30272823
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Isosteviol Derivative Inhibits Osteoclast Differentiation and Ameliorates Ovariectomy-Induced Osteoporosis.
    Tzeng HE, Huang PH, Tsai CH, Tsay GJ, Lee YJ, Huang TJ, Lin TH, Chiu YM, Wu YY.
    Sci Rep; 2018 Jul 25; 8(1):11190. PubMed ID: 30046042
    [Abstract] [Full Text] [Related]

  • 40. Proanthocyanidins inhibit osteoclast formation and function by inhibiting the NF-κB and JNK signaling pathways during osteoporosis treatment.
    Zhu W, Yin Z, Zhang Q, Guo S, Shen Y, Liu T, Liu B, Wan L, Li S, Chen X, Ouyang Z, Peng D.
    Biochem Biophys Res Commun; 2019 Jan 29; 509(1):294-300. PubMed ID: 30583865
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.